Gottlieb will speak at two sessions during the AIHD Conference, which takes place May 10-11 in San Jose. Expect his focus to be on the state of AI in healthcare.
AI in Healthcare and Diagnostics
Walmart’s large size and vast resources should cause strategic-minded healthcare leaders to pay attention to moves the retail company is making.
A new study in Nature Medicine explains how a competition called PANDA (Prostate cANcer graDe Assessment) developed an AI system that can diagnose and grade prostate cancer.
Healthcare executives, biotech leaders, and innovators at artificial intelligence companies will gather in San Jose.
Researchers questioned what distinguishes mutations in terms of clinical relevance, the goal to identify genes responsible for the spread of cancer cells.
Innovative hospital leaders following precision medicine developments will benefit from understanding how precision medicine is developing beyond genetics.
A new database and Google AI may open new avenues of scientific inquiry that will advance understanding of many areas of biology and of life itself.
With a new Kidney Care Choices model starting January 1, 2022, hospital executives may be considering strategies, including precision medicine strategies.